Chemopreventive effect of difluoromethylornithine (DFMO) on mouse skin squamous cell carcinomas induced by benzo(a)pyrene

Journal of Cellular Biochemistry

Volumn 67, Issue SUPPL. 28/29, 1997, Pages 81-89

  Mitsunaga, Shin Ichiro ^a,b   Clapper, Margie ^a   Litwin, S ^a   Watts, P ^a   Bauer, B ^a   Klein Szanto, A J P ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Benzo (a)pyrene; Chemoprevention; Difluoromethylornithine; Skin tumor markers; Squamous cell carcinoma

Indexed keywords

ACETONE; BENZO[A]PYRENE; DRUG VEHICLE; EFLORNITHINE; CARCINOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CARCINOMA IN SITU; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFECT; EPIDERMIS HYPERPLASIA; FEMALE; HISTOPATHOLOGY; MORPHOMETRICS; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; TOPICAL DRUG ADMINISTRATION; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; HYPERPLASIA; PATHOLOGY; PRECANCER; SKIN; SKIN TUMOR;

ANIMALS; BENZO(A)PYRENE; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; EFLORNITHINE; FEMALE; HYPERPLASIA; MICE; PRECANCEROUS CONDITIONS; SKIN; SKIN NEOPLASMS;

EID: 0031401901     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(1997)28/29+<81::AID-JCB9>3.0.CO;2-S     Document Type: Article

References (34)

1. Glucksmann A (1945): The histogenesis of benzopyrene-induced epidermal tumors in the mouse. Cancer Res 5:385-400.
2. Albert RE, Miller ML, Cody T, Andringa A, Shukla R, Baxter CS (1991): Benzo(a)pyrene-induced skin damage and tumor promotion in the mouse. Carcinogenesis 12:1273-1280.
3. Ruggeri B, DiRado M, Zhang SY, Bauer B, Goodrow T, Klein-Szanto AJP (1994): Benzo(a)-pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene. Proc Natl Acad Sci USA 90:1013-1017.
4. Mitsunaga SI, Zhang SY, Ruggeri BA, Gimenez-Conti I, Robles AI, Conti CJ, Klein-Szanto AJP (1995): Positive immunohistochemical staining of p53 and cyclin D in advanced mouse skin tumors, but not in precancerous lesions produced by benzo(a)pyrene. Carcinogenesis 16:1629-1635.
5. Schwartz AG, Fairman DK, Polansky M, Lewbart ML, Pashko LL (1989): Inhibition of 7,12-dimethylbenz(a)anthracene-initiated and 12-O-tetradecanoylphorbol-13-acetate promoted skin papilloma formation in mice by dehydroepiandrosterone and two synthetic analogs. Carcinogenesis 10:1809-1813.
6. Furstenberger G, Amtmann E, Marks F, Sauer G (1989): Tumor prevention by a xanthate compound in experimental mouse-skin tumorigenesis. Int J Cancer 43:508-512.
7. Murakoshi M, Nishino H, Satomi Y, Takayasu J, Hasegawa T, Tokuda H, Iwashima A, Okuzumi J, Okabe H, Kitano H, Iwasaki R (1992): Potent preventive action of a-carotene against carcinogenesis: Spontaneous liver carcinogenesis and promoting stage of lung and skin carcinogenesis in mice are suppressed more effectively by α-carotene than by β-carotene. Cancer Res 52:6583-6587.
8. Chen L-C, Sly L, Jones CS, Tarone R, DeLuca LM (1993): Differential effects of dietary β-carotene on papilloma and carcinoma formation induced by an initiation-promotion protocol in SENCAR mouse skin. Carcinogenesis 14:713-717.
9. Strickland JE, Dlugosz AA, Hennings H, Yuspa SH (1993): Inhibition of tumor formation from grafted murine papilloma cells by treatment of grafts with staurosporine, an inducer of squamous differentiation. Carcinogenesis 14:205-209.
10. Pence BC, Delver E, Dunn DM (1994): Effects of dietary selenium on UVB-induced skin carcinogenesis and epidermal antioxidant status. J Invest Dermatol 102:759-761.
11. Verma AK (1995): Protein kinase C and skin cancer prevention. In Mukhtar H (ed): "Skin Cancer: Mechanisms and Human Relevance." Boca Raton, FL: CRC Press, pp 382-390.
12. Agarwal R, Katiyar SK, Mukhtar H (1995): Skin cancer chemoprevention by naturally occurring polyphenols. In Mukhtar H (ed): "Skin Cancer: Mechanisms and Human Relevance." Boca Raton, FL: CRC Press, pp 391-400.
13. Chen L-C, DeLuca LM (1995): Retinoid effects on skin cancer. In Mukhtar H (ed): "Skin Cancer: Mechanisms and Human Relevance." Boca Raton, FL: CRC Press, pp 401-426.
14. Pegg AE, McCann PP (1982): Polyamine metabolism and function. Am J Physiol 243:C212-C221.
15. Verma AK (1989): The enzyme-activated irreversible inhibitor of ornithine decarboxylase, D,L-α-difluoromethylornithine: A chemopreventive agent. Prev Med 18:646-652.
16. Pegg AE (1986): Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J 234:249-262.
17. O'Brien TG (1976): The induction of ornithine decarboxylase as an early, possibly obligatory, event in mouse skin carcinogenesis. Cancer Res 36:2644-2653.
18. Verma AK, Loprinzi CL, Boutwell RK, Carbone PP (1985): In vitro induction of human skin ornithine decarboxylase by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. JNCI 75:85-90.
19. Weeks CE, Herrmann AL, Nelson FR, Slaga TJ (1982): α-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin. Proc Natl Acad Sci USA 79:6032-6032.
20. Takigawa M, Verma AK, Simsiman RC, Boutwell RK (1983): Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine biosynthesis by α-difluoromethylornithine. Cancer Res 43:3732-3738.
21. Tanaka T, Kojima T, Hara A, Sawada H, Mori H (1993): Chemoprevention of oral carcinogenesis by D,L-α-difluoromethylornithine, an ornithine decarboxylase inhibitor: Dose-dependent reduction in 4-nitroquinoline 1-oxide-induced tongue neoplasms in rats. Cancer Res 53:772-776.
22. Reddy B, Nayini J, Tokumo K, Rigotty J, Zang E, Kelloff G (1990): Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a non-steroidal anti-inflammatory drug with D,L-α-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res 50:2562-2568.
23. Rao CV, Tokumo K, Rigotty J, Zang E, Kelloff G, Reddy BS (1991): Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, a-difluoromethylornithine, 16-a-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. Cancer Res 51: 4528-4534.
24. Singh J, Kelloff G, Reddy BS (1993): Intermediate biomarkers of colon cancer: Modulation of expression of ras oncogene by chemopreventive agents during azoxymethane induced colon carcinogenesis. Carcinogenesis 14:699-704.
25. McGarity T, Peiffer LP (1993): Selenium and difluoromethylornithine additively inhibit DMH-induced distal colon tumors formation in rats fed a fiber-free diet. Carcinogenesis 14:2335-2340.
26. Thompson HJ, Herbst EJ, Meeker LD, Monocha R, Roman AM, Fite R (1984): Effect of concentratio of D,L-a-difluoromethylornithine on murine mammary carcinogenesis. Carcinogenesis 5:1649-1651.
27. Homma Y, Kakizoe T, Samma S, Oyasu R (1987): Inhibition of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat urinary bladder carcinogenesis by a-fluoromethylornithine. Cancer Res 47:6176-6179.
28. Kingsnorth AN, McCann PP, Diekema KA, Ross JS, Malt RA (1983): Effects of a-difluoromethylornithine on the growth of experimental Wilms' tumors and renal adenocarcinoma. Cancer Res 43:4031-4034.
29. Kojima T, Tanaka T, Kawamori T, Kara A, Mori H (1993): Chemopreventive effects of dietary D,L-a-difluoromethylornithine, an ornithine decarboxylase inhibitor, on initiation and postinitiation stages of diethylnitrosamine-induced rat hepatocarcinogenesis. Cancer Res 53:3903-3907.
30. Abeloff MD, Slavik M, Luk GD, Griffin CA, Hermann J, Blanc O, Sjoerdsma A, Baylin SB (1984): Phase I trial and pharmacokinetic studies of a-difluoromethylornithine: An inhibitor of polyamine biosynthesis. J Clin Oncol 2:124-130.
31. Love RR, Carbone PP, Verma AK, Gilmore D, Carey P, Tutsch KD, Pomplun M, Wilding G (1993): Randomized Phase I chemoprevention dose-seeking study of a-difluoromethylornithine. J Natl Cancer Inst 85:732-737.
32. Pendyala L, Creaven PJ, Porter CW (1993): Urinary and erythrocyte polyamines during the evaluation of oral a-difluoromethylornithine in a Phase I chemoprevention clinical trial. Cancer Epidemiol Biomark Prev 2:235-241.
33. Kelloff GJ, Boone CW, Crowell JA, Steele VE, Lubet R, Sigman CC (1994): Chemopreventive drug development: Perspectives and progress. Cancer Epidemiol Biomark Prev 3:85-98.
34. Boone CW, Kelloff GJ, Freedman LS (1993): Intraepithelial and postinvasive neoplasia as a stochastic continuum of clonal evolution, and its relationship to mechanisms of chemopreventive drug action. J Cell Biochem 17G:14-25.